Elevance Health, Inc. (LON:0HG8)
London · Delayed Price · Currency is GBP · Price in USD 339.35
+0.33 (0.10%)
At close: Nov 28, 2025
Elevance Health Market Cap
Elevance Health has a market cap or net worth of 56.79 billion as of November 28, 2025. Its market cap has decreased by -24.40% in one year.
Market Cap
56.79B
Enterprise Value
74.56B
Revenue
144.93B
Ranking
n/a
PE Ratio
13.80
Stock Price
339.35
Market Cap Chart
Since October 30, 2001, Elevance Health's market cap has increased from 2.89B to 56.79B, an increase of 1,863.54%. That is a compound annual growth rate of 13.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 56.79B | -16.90% |
| Dec 31, 2024 | 68.34B | -21.43% |
| Dec 29, 2023 | 86.98B | -14.45% |
| Dec 30, 2022 | 101.68B | 22.37% |
| Dec 31, 2021 | 83.09B | 42.06% |
| Dec 31, 2020 | 58.49B | 1.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.39B |
| GSK plc | 72.88B |
| Haleon | 33.03B |
| Smith & Nephew | 10.71B |
| ConvaTec Group | 4.61B |
| Hikma Pharmaceuticals | 3.45B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.68B |